Development Program. (a) VIA shall, at its expense, conduct a clinical and commercial development program relating to the use of a Licensed Product using commercially reasonable efforts (“Development Program”) consistent with a Development Plan that is to be provided to Roche as soon as practicable after creation by VIA. VIA shall provide on a once yearly basis written reports to the Global Liaison on the progress of the Development Program, and annually shall provide to the Global Liaison a written overview of material Development Program activities.
Appears in 4 contracts
Samples: And Commercialization Agreement, And Commercialization Agreement (Madrigal Pharmaceuticals, Inc.), Research, Development and Commercialization Agreement (Via Pharmaceuticals, Inc.)
